Open-label safety study of TMC114 [darunavir] in combination with low dose RTV and other ARVs in highly experienced HIV-1 infected patients with limited or no treatment options
Phase of Trial: Phase III
Latest Information Update: 02 Jun 2011
At a glance
- Drugs Darunavir; Ritonavir
- Indications HIV-1 infections
- Focus Adverse reactions
- 03 Nov 2009 Actual number of patients (260) added from ClinicalTrials.gov record.
- 26 Jan 2008 Status changed from in progress to completed (source: ClinicalTrials.gov).
- 16 Feb 2006 New trial record.